Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking. [electronic resource]
Producer: 20190708Description: 131-141 p. digitalISSN:- 1538-7836
- Aged
- Blood Coagulation -- drug effects
- Blood Coagulation Factors -- adverse effects
- Coagulants -- adverse effects
- Factor VIII -- adverse effects
- Factor VIIa -- adverse effects
- Factor XIII -- adverse effects
- Female
- Fibrin -- chemistry
- Hemophilia A -- blood
- Humans
- Male
- Middle Aged
- Recombinant Proteins -- therapeutic use
- Time Factors
- Treatment Outcome
- alpha-2-Antiplasmin -- metabolism
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.